Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 5

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 4,001–5,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
4001Cholesteryl esters in large VLDL (UKB data field 23499)GCST902695960.84
4002OPHN1 levelsGCST904701260.84
4003Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T389ECGU0003890.84
4004T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116)GCST903209350.84
4005Polyunsaturated fatty acid levelsGCST904992660.84
4006CHAD levelsGCST904687370.84
4007Beer or cider consumption (glasses per month) (UKB data field 1578, 4420)GCST901329880.84
4008Sphingomyelin_34:0_[M+H]1+ levelsGCST900602410.84
4009MYO9B levelsGCST904699820.84
4010OXCT1 levelsGCST904701380.84
4011CIAPIN1/VEGFC ratioGCST903140710.84
4012Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T329ECGU0003290.84
4013Milk type used: Full cream (UKB data field 1418_1)GCST901329380.84
4014Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levelsGCST900603180.84
4015Lysoalkylphosphatidylcholine (O-24:1) levelsGCST900248130.84
4016LBR/POLR2F ratioGCST903152970.84
4017wg lh intensity-contrast lateralorbitofrontalGCST900038030.84
4018Alzheimer's disease (MTAG)GCST904490600.84
4019Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900250560.84
4020Total triglycerides levels (UKB data field 23407)GCST902695040.83
4021DTI TBSS MD Superior longitudinal fasciculus RGCST903846120.83
4022Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T321ECGU0003210.83
4023PDGFRA levelsGCST904701910.83
4024IDP dMRI TBSS L2 Genu of corpus callosumGCST900041250.83
4025T1 FreeSurfer aseg Left-choroid-plexusGCST903841560.83
4026ITGA5 levelsGCST904696350.83
4027Polyunsaturated fatty acids to total fatty acids percentageGCST905021730.83
4028Hands-free device/speakerphone use with mobile phone in last 3 month | Electronic device useUKBB000003040.83
4029PSMG3 levelsGCST904703620.83
4030Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98ECGU0000980.83
4031TACSTD2 levelsGCST904707980.83
4032Esophageal cancerGCST900186210.83
4033Basal metabolic rate | Impedance measuresUKBB000000860.83
4034COLEC12 levelsGCST904688240.83
4035Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T92ECGA0000920.83
4036Fracture of femurFING000005520.83
4037Lactate levels (UKB data field 23471)GCST902695680.83
4038CD69/F2R ratioGCST903138770.83
4039DRG2 levelsGCST904690390.83
4040Concentration of small VLDL particlesGCST904998680.83
4041Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334ECGU0003340.83
4042Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T128ECGA0001280.83
4043Prescriptions - sulfonylurea|diabetesUKBB000007030.83
4044Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481ECGU0004810.83
4045aseg lh volume Inf-Lat-VentGCST900026170.82
4046IDP dMRI TBSS FA Anterior corona radiata LGCST900039000.82
4047MANSC1 levelsGCST904698470.82
4048FLT3LG levelsGCST902747910.82
4049Breast cancerGCST904298460.82
4050Total lipids in very large HDLGCST905004230.82
4051Obstructed labour due to maternal pelvic abnormalityFING000008990.82
4052Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340ECGU0003400.82
4053Average diameter for LDL particlesGCST904984570.82
4054Cholesterol to Total Lipids in Small HDL percentageGCST904993730.82
4055Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T151ECGA0001510.82
4056IDP dMRI TBSS ISOVF Superior corona radiata RGCST900045010.82
4057IDP dMRI TBSS MO Posterior limb of internal capsule RGCST900039700.82
4058Mental and behavioural disorders due to use of other stimulants, including caffeineFING000008110.82
4059ARHGEF5 levelsGCST904683600.82
4060CXCL17/LAMP3 ratioGCST903143400.82
4061Free cholesterol in small VLDLGCST904998170.82
4062SEC31A levelsGCST904705630.82
4063Triglycerides to Total Lipids in Small HDL percentageGCST904995430.82
4064CRKL levelsGCST904688670.82
4065Monounsaturated fatty acid levelsGCST905023590.82
4066LAT/PLXNA4 ratioGCST903152860.82
4067RELT levelsGCST904704530.82
4068FBLN2 levelsGCST904691930.82
4069IGFBP3 levelsGCST901026240.82
4070Operation code - anterior/posterior repair bladder/uterus | OperationsUKBB000005480.81
4071Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)FING000007520.81
4072Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253ECGU0002530.81
4073Other specified cardiac dysrhythmias (PheCode 427.3)GCST904759750.81
4074IGDCC4 levelsGCST904695230.81
4075APOE levelsGCST904683380.81
4076IDP dMRI TBSS ISOVF Posterior corona radiata RGCST900045030.81
4077rfMRI connectivity (ICA100 edge 1090)GCST900059430.81
4078IDP dMRI ProbtrackX L2 ptr lGCST900042920.81
4079PLXNA4/SRPK2 ratioGCST903156880.81
4080aparc-a2009s lh area G-cingul-Post-ventralGCST900033060.81
4081C36:4 Phosphatidylethanolamine levels in chronic kidney diseaseGCST902573570.81
4082CD46/NECTIN2 ratioGCST903138320.81
4083FCN2 levelsGCST904692040.81
4084Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T227ECGA0002270.81
4085MVK levelsGCST904699670.81
4086KRT18 levelsGCST904697160.81
4087Principal component-derived dietary pattern 40GCST901330450.81
4088Body fat percentage (UKB data field 23099)GCST904681600.81
4089Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195ECGA0001950.81
4090Do you currently smoke cigarettes?GCST904763880.81
4091AMIGO2 levelsGCST904682920.81
4092N-formylmethionine levelsGCST902003430.81
4093Lymphoid leukemia, chronic (PheCode 204.12)GCST904756130.81
4094ADGRG2 levelsGCST904682410.81
4095IDP dMRI ProbtrackX L3 cst lGCST900043080.81
4096KLK11 levelsGCST904696970.81
4097aseg rh volume CerebralWhiteMatterGCST900026320.81
4098IDP dMRI TBSS FA Retrolenticular part of internal capsule RGCST900038970.81
40993,4-dihydroxybutyrate levelsGCST901998160.80
4100aparc-a2009s lh thickness Pole-occipitalGCST900036440.80
4101Left ventricular end diastole anterior wall thicknessGCST902785180.80
4102PGD levelsGCST904702170.80
4103Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T125ECGA0001250.80
4104Hypertension (PheCode 401)GCST904759190.80
4105SERPINE1/USP8 ratioGCST903158350.80
4106Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000008120.80
4107DTI TBSS FA Sagittal stratum RGCST903844100.80
4108IDP dMRI TBSS MD Middle cerebellar peduncleGCST900040270.80
4109ConjunctivitisFING000003460.80
4110Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T218ECGU0002180.80
4111Hippocampal right HATA volumeGCST902679690.80
4112Medication use (vasodilators used in cardiac diseases)GCST900187630.80
4113FOLR1 levelsGCST904692590.80
4114Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T212ECGA0002120.80
4115Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T337ECGA0003370.80
4116IDP dMRI TBSS FA Anterior corona radiata RGCST900038990.80
4117BLOC1S3 levelsGCST904684500.80
4118CRELD2 levelsGCST904688590.80
4119Low density lipoprotein cholesterol levelsGCST902396570.80
4120MGLL/PDLIM7 ratioGCST903154380.80
4121Lung cancerGCST0047480.80
4122DNAJB1/PPME1 ratioGCST903145100.80
4123Asthma mixed form (mode) (more control exclusions)FING000001160.80
4124Non-cancer illness code, self-reported - high cholesterol | Medical conditionsUKBB000005160.80
4125Valine levelsGCST900929950.80
4126AmygNuclei lh volume Cortical-nucleusGCST900026540.80
4127APOBR levelsGCST904683340.80
4128aparc-a2009s rh thickness Pole-temporalGCST900037190.80
4129Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T113ECGA0001130.79
4130ENO2/FXYD5 ratioGCST903146590.79
4131Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207ECGA0002070.79
4132Gastric ulcerGCST902709270.79
4133DTI TBSS L3 FornixGCST903845290.79
4134CD244/GP1BA ratioGCST903137660.79
4135T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903206880.79
4136DUSP3 levelsGCST904690530.79
4137NUDT2 levelsGCST904701060.79
4138Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755930.79
4139Skin sebum (glabella)GCST905027970.79
4140Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228ECGA0002280.79
4141Other arthropathies | musculoskeletalUKBB000006010.79
4142FIS1/HSPA1A ratioGCST903148250.79
4143aparc-DKTatlas rh thickness lateraloccipitalGCST900035800.79
4144MAP2K1 levelsGCST904698510.79
4145total cholesterol (minimum, inv-norm transformed)GCST904764270.79
4146Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T349ECGU0003490.79
4147PDCD5 levelsGCST904701820.79
4148ARHGEF10 levelsGCST904683570.79
4149TCTN3 levelsGCST904708230.79
4150T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903205660.79
4151Primary biliary cholangitis (PBC)FING000012110.79
4152CNPY4/STAT5B ratioGCST903141550.79
4153Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95ECGU0000950.79
4154HSPB6 levelsGCST904694900.79
4155Concentration of chylomicrons and extremely large VLDL particlesGCST905010150.79
4156Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496ECGA0004960.79
4157HypertensionGCST904681350.79
4158APOA1 levelsGCST902695370.79
4159BPIFB2 levelsGCST904684630.79
4160SH2B3 levelsGCST904706160.79
4161IL1RL1 levelsGCST904695740.78
4162Free cholesterol to total lipids ratio in large VLDLGCST900928730.78
4163CNTN1/EGFR ratioGCST903141620.78
4164CCL13 levelsGCST904685650.78
4165ATP5IF1/FIS1 ratioGCST903133850.78
4166Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62ECGU0000620.78
4167Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84ECGA0000840.78
4168Free cholesterol in medium HDLGCST904985620.78
4169HPSE levelsGCST904694730.78
4170VGF levelsGCST904710380.78
4171Blood cell traits latent factor 1 (white cell)GCST905592430.78
4172Degree of unsaturationGCST905022250.78
4173BIRC2 levelsGCST904684460.78
4174Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490ECGU0004900.78
4175Recent feelings of inadequacy | DepressionUKBB000007390.78
4176PMM2 levelsGCST904702700.78
4177MANF/PDGFB ratioGCST903153600.78
4178Heart rate variability (standard deviation of normal-to-normal intervals)GCST902812650.78
4179Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605060.78
4180NECTIN2/SPON2 ratioGCST903155300.78
4181Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T215ECGU0002150.78
4182Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T323ECGU0003230.78
4183NUCB2 levelsGCST904701010.78
4184Cholesteryl Esters to Total Lipids in Medium HDL percentageGCST904985560.78
4185VAV3 levelsGCST904710300.78
4186AGRP levelsGCST904682560.78
4187Total lipids in VLDL (UKB data field 23424)GCST902695210.77
4188Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009830.77
4189IDP T1 FAST ROIs R front operc cortexGCST900025320.77
4190Subarachnoid hemorrhageGCST900187030.77
4191Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T149ECGU0001490.77
4192PEAR1/SNAP23 ratioGCST903156430.77
4193TNFRSF21 levelsGCST904709120.77
4194Internal derangement of knee (PheCode 835)GCST904762820.77
4195Triglycerides in large HDLGCST904978880.77
4196Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST902697230.77
4197NRSN1 levelsGCST902420620.77
4198Concentration of HDL particlesGCST904974060.77
4199Chronic obstructive pulmonary disease liability (machine learning-based score)GCST902440980.77
4200IPCEF1/TBCC ratioGCST903151880.77
4201Triglyceride to phosphoglyceride ratioGCST904544830.77
4202IDP dMRI ProbtrackX ICVF ptr lGCST900043940.77
4203Liver enzyme levels (alanine transaminase)GCST900134050.77
4204EGF/MANF ratioGCST903146090.77
4205CD58/LTBR ratioGCST903138510.77
4206MSR1/TNFRSF21 ratioGCST903154940.77
4207Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T261ECGU0002610.77
4208MILR1 levelsGCST904699070.77
4209LRPAP1 levelsGCST904698000.77
4210IDP dMRI TBSS L3 Anterior corona radiata RGCST900041930.76
4211Hip circumferenceGCST902786330.76
4212TXLNA levelsGCST904709890.76
4213Degree of unsaturationGCST905001750.76
4214GP6 levelsGCST904693840.76
4215T1 CAT volume L IXGCST903841330.76
4216Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T386ECGU0003860.76
4217Plasma propionylcarnitine (C3) levels in chronic kidney diseaseGCST902658760.76
4218Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202ECGA0002020.76
4219Chronic osteomyelitis (PheCode 710.12)GCST904762230.76
4220aparc-Desikan rh area TotalSurfaceGCST900031070.76
4221Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336ECGU0003360.76
4222RAB2B levelsGCST904704060.76
4223Triglycerides in small VLDLGCST904999150.76
4224KLK8/LY6D ratioGCST903152570.76
4225wg lh intensity-contrast isthmuscingulateGCST900038010.76
4226CA13 levelsGCST904685080.76
4227CC2D1A/WWP2 ratioGCST903136680.76
4228Triglycerides to Total Lipids in Large VLDL percentageGCST904982870.76
4229WFIKKN1 levelsGCST904710760.76
4230Cholesteryl Esters in Medium HDLGCST904985380.76
4231HippSubfield lh volume presubiculum-headGCST900026730.76
4232TCN1 levelsGCST904708190.76
4233FCRL2/SEMA7A ratioGCST903148000.76
4234Triacylglycerol_50:2_[M+NH4]1+ levelsGCST900604730.75
4235REST UKBBICA NET100 1111GCST903869650.75
4236BST1 levelsGCST904684740.75
4237Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T210ECGA0002100.75
4238Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T333ECGA0003330.75
4239Mean platelet volume during the postpartum periodGCST903022330.75
4240NFKBIE levelsGCST904700390.75
4241Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T321ECGA0003210.75
4242Free androgen indexGCST902398230.75
4243Shoulder lesions | Other soft tissue disordersUKBB000007690.75
4244HYAL1 levelsGCST904694950.75
4245PPCDC/RWDD1 ratioGCST903157040.75
4246Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203ECGA0002030.75
4247Cholesteryl Esters in VLDLGCST905002050.75
4248GRAP2/TYMP ratioGCST903149900.75
4249DTI TBSS MD Fornix cres+Stria terminalis LGCST903846110.75
4250T1 FreeSurfer pial rh posteriorcingulate areaGCST903858440.75
4251HBEGF levelsGCST900120670.75
4252aparc-a2009s rh area G+S-subcentralGCST900033740.75
4253Abdominal subcutaneous adipose tissue normalizedGCST902673480.75
4254NELL1 levelsGCST902424810.75
4255Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T294ECGU0002940.75
4256Melanocytic naevi, other sites/unspecifiedFING000008020.75
4257Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339ECGU0003390.75
4258FSTL3/LTBR ratioGCST903148830.75
4259Frailty (Factor 3 - Multimorbidity)GCST906240490.75
4260TRIM24 levelsGCST904709650.75
4261Left ventricular end diastole anterospetal wall thicknessGCST902785190.75
4262Concentration of very large VLDL particlesGCST905006310.75
4263Synonym | Fluid intelligence / reasoningUKBB000008020.74
4264Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003730.74
4265CELA3A/PLA2G1B ratioGCST903140140.74
4266Sphingomyelin_36:2_[M+H]1+ levelsGCST900602630.74
4267Left-hemisphere limbic network to caudate white-matter structural connectivityGCST903027370.74
42685alpha-androstan-3beta,17beta-diol disulfate levelsGCST901998350.74
4269CXCL6/DFFA ratioGCST903143570.74
4270CSPG4 levelsGCST904688900.74
42711-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levelsGCST901996490.74
4272ACOX1/VSIR ratioGCST903131550.74
4273rfMRI amplitudes (ICA100 node 38)GCST900046260.74
4274EHD3 levelsGCST904690890.74
4275aparc-a2009s lh volume G-front-inf-OpercularGCST900029360.74
4276Volume of left whole amygdalaGCST904748980.74
4277rfMRI amplitudes (ICA25 node 14)GCST900045810.74
4278EIF4G1/PLA2G4A ratioGCST903146380.74
4279Emotional neglectGCST905518460.74
4280Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74ECGU0000740.74
4281Speech-in-noise perceptionGCST900447760.74
4282INPPL1 levelsGCST904696190.74
4283Stroke (MTAG)GCST904490630.74
4284Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T320ECGU0003200.74
4285Disorders of synovium and tendonFING000004620.73
4286Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54ECGA0000540.73
4287Gouty arthropathy (PheCode 274.11)GCST904757380.73
4288Pain (PheCode 338)GCST904758360.73
4289Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992880.73
4290TFPI levelsGCST904708390.73
4291Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182ECGU0001820.73
4292Diseases of arteries, arterioles and capillaries (FINNGEN)FING000004230.73
4293KITLG levelsGCST900120230.73
4294SpondylopathiesFING000013250.73
4295CCN1 levelsGCST904685870.73
4296IDP dMRI TBSS ICVF Superior longitudinal fasciculus RGCST900043670.73
4297CA13/TIA1 ratioGCST903135670.73
4298Triglycerides in medium HDLGCST904986720.73
4299LRRN1 levelsGCST904698060.73
4300Aspartate aminotransferase levelsGCST902786180.73
4301APOH levelsGCST904683400.73
4302Phospholipids in small HDLGCST904994830.73
4303TRAF2/WWP2 ratioGCST903159430.73
4304Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T59ECGU0000590.73
4305Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T259ECGU0002590.73
4306Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T233ECGU0002330.73
4307Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T323ECGA0003230.73
4308CD46 levelsGCST904686340.73
4309IDP dMRI TBSS FA Posterior thalamic radiation RGCST900039050.73
4310Massiliomicrobiota abundance in stoolGCST900324700.73
4311Benign neoplasm of colon, rectum, anus and anal canal | Benign neoplasmsUKBB000000930.73
4312Concentration of medium VLDL particlesGCST904990170.73
4313Triglycerides in LDLGCST904984720.73
4314SERPINE1/VASH1 ratioGCST903158360.73
4315Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T226ECGA0002260.73
4316Triglycerides to Total Lipids in Small HDL percentageGCST904995300.73
4317CANT1/HSPB1 ratioGCST903136170.73
4318Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T440ECGA0004400.73
4319Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T261ECGA0002610.73
4320Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162ECGA0001620.73
4321Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759840.72
4322Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981650.72
4323IGF1 levelsGCST901026230.72
4324Ratio of triglycerides to phosphoglyceridesGCST900929830.72
4325Hepatomegaly (PheCode 573.3)GCST904760920.72
4326SDC4/WWP2 ratioGCST903158210.72
4327PEAR1/PECAM1 ratioGCST903156410.72
4328TJAP1 levelsGCST904708740.72
4329Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T295ECGU0002950.72
4330Treatment/medication code - bendroflumethiazide | MedicationsUKBB000008430.72
4331Disorders of plasma-protein metabolism, not elsewhere classifiedFING000004550.72
4332Malignant neoplasm of liver, primary (PheCode 155.1)GCST904755690.72
4333Percentage of M9 (GP18)GCST906686960.72
4334Volume of right cortical nucleusGCST904750300.72
4335Cholesterol to Total Lipids in Large VLDL percentageGCST904981300.72
4336PPME1 levelsGCST904702980.72
4337Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST900440250.72
4338IDP dMRI ProbtrackX L1 fmiGCST900042570.72
4339Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)FING000007540.72
4340Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T90ECGU0000900.72
4341Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T348ECGU0003480.72
4342NT5E levelsGCST904700930.72
4343EIF4G1/MAVS ratioGCST903146360.72
4344KIFBP/TBC1D23 ratioGCST903152500.72
4345FABP9 levelsGCST904691790.72
4346Pregnanediol-3-glucuronide levelsGCST901999170.72
4347Total triglycerides levelsGCST905001400.72
4348B4GALT1/SMOC2 ratioGCST903134330.71
4349Androstenediol (3beta,17beta) monosulfate (2) levelsGCST901998710.71
4350Other diseases of liverFING000010040.71
4351QDPR levelsGCST904704000.71
4352MNX1 levelsGCST900907580.71
4353Operation code - tonsillectomy +/- adenoids | OperationsUKBB000005670.71
4354ADH4/KRT18 ratioGCST903131920.71
4355Arthropathy NOS | musculoskeletalUKBB000000510.71
4356CDH1/CST3 ratioGCST903139460.71
4357TNFRSF4/TNFRSF8 ratioGCST903159380.71
4358Retinal detachment with retinal breakFING000012590.71
4359Plasma succinylcarnitine (C4-DC) levels in chronic kidney diseaseGCST902659980.71
4360Triglyceride to phosphoglyceride ratioGCST904999920.71
4361Acute pancreatitisGCST900185690.71
4362LBR levelsGCST904697440.71
4363ITGB5/S100A4 ratioGCST903152330.71
4364Total lipid levels in chylomicrons and extremely large VLDLGCST905009940.71
4365ENDOU levelsGCST904691070.71
4366DNAJA2 levelsGCST904690090.71
4367QC T2 FLAIR-to-T1 linear alignment discrepancyGCST900063500.71
4368Benign neoplasm: RectumFING000001960.71
4369T1 FreeSurfer aseg MaskVol-to-eTIVGCST903841920.71
4370Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activityUKBB000008700.71
4371F7/PROC ratioGCST903147440.71
4372DIABLO levelsGCST904689940.71
4373CD48/FCRL6 ratioGCST903138400.70
4374SCGN levelsGCST904705440.70
4375Meniscus derangementFING000008070.70
4376CNTNAP4 levelsGCST904688090.70
4377ObesityGCST0014750.70
4378DOK2/SNX9 ratioGCST903145390.70
4379Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220ECGU0002200.70
4380Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T333ECGU0003330.70
4381Atherosclerosis, excluding cerebral and coronary sclerosisFING000001230.70
4382PF4 levelsGCST904702110.70
4383ADAMTSL5 levelsGCST904682300.70
4384INPP1 levelsGCST904696160.70
4385Heart rate variability traits (RMSSD)GCST0047330.70
4386Hereditary ataxiaFING000006100.70
4387Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T149ECGA0001490.70
4388DTI autoptx MD atr l tractGCST903852220.70
4389Triglycerides to Total Lipids in Large LDL percentageGCST904980920.70
4390IDP dMRI TBSS MD Anterior corona radiata RGCST900040490.70
4391Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T336ECGA0003360.70
4392Volume of left cortico-amygdaloid transition areaGCST904748800.70
4393Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010500.70
4394DECR1 levelsGCST904689780.70
4395ATXN10/CASP10 ratioGCST903133960.70
4396T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73)GCST903206360.69
4397Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T264ECGA0002640.69
4398Right-hemisphere dorsal attention network to pallidum white-matter structural connectivityGCST903028090.69
4399Phospholipids to Total Lipids in Large VLDL percentageGCST904982520.69
4400Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB000006700.69
4401Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB000006580.69
4402Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266ECGU0002660.69
4403Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T335ECGA0003350.69
4404Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025970.69
4405IDP dMRI ProbtrackX ICVF ptr rGCST900043950.69
4406Cholesteryl esters to total lipids ratio in very large HDLGCST900930070.69
4407ATP5IF1 levelsGCST904683920.69
4408wg lh intensity-contrast precentralGCST900038150.69
4409Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466ECGU0004660.69
4410Other cataractFING000009760.69
4411Propionylcarnitine levelsGCST902435930.69
4412Triacylglycerol_52:4_[M+NH4]1+ levelsGCST900605080.69
4413Biological Grandparent (paternal): Coronary Artery / Coronary Heart DiseaseGCST904755480.69
4414Phospholipids to Total Lipids in Large HDL percentageGCST904978680.69
4415Cholesterol levels in very large VLDLGCST905005180.69
4416DTI TBSS L2 Superior fronto-occipital fasciculus RGCST903845180.69
4417Treatment/medication code - paracetamol | MedicationsUKBB000008530.69
4418Pre-eclampsia or eclampsiaFING000012010.69
4419Free cholesterol in large LDLGCST904979870.69
4420CCL7 levelsGCST904685850.69
4421WARS levelsGCST904710660.68
4422SSNA1 levelsGCST904707500.68
4423CDKN1A/TMSB10 ratioGCST903139780.68
4424Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T338ECGA0003380.68
4425Heart failureGCST0095410.68
4426Free cholesterol in large LDLGCST904979810.68
4427DBNL levelsGCST904689510.68
4428NFATC1/TJAP1 ratioGCST903155400.68
4429CFHR5 levelsGCST904687280.68
4430Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60ECGA0000600.68
4431Ratio of polyunsaturated fatty acids to total fatty acidsGCST900929410.68
4432Omega-3 fatty acids to total fatty acids percentageGCST905020880.68
4433Right ventricular end diastolic volumeGCST902681160.68
4434Glycine levelsGCST902435810.68
4435Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448ECGA0004480.68
4436Coxarthrosis, primaryFING000003630.68
4437MOG/SEZ6L ratioGCST903154770.68
4438Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T330ECGU0003300.68
4439NUBP1 levelsGCST904701000.68
4440CC2D1A/TMSB10 ratioGCST903136670.68
4441AXL/MCAM ratioGCST903134210.68
4442CRHBP levelsGCST904688600.68
4443Polyunsaturated fatty acids to total fatty acids percentageGCST905026330.68
4444Concentration of very large HDL particlesGCST905004310.68
4445NUCB2/TRIAP1 ratioGCST903155770.68
4446Fat-free massGCST0070630.68
4447Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levelsGCST900602700.68
4448DTI TBSS L3 Cingulum hippocampus LGCST903845610.68
4449Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T200ECGA0002000.68
4450aseg lh intensity Cerebellum-CortexGCST900037670.68
4451NMI levelsGCST904700560.68
4452CD83/TREM2 ratioGCST903139080.68
4453CD27/TNFRSF9 ratioGCST903137780.68
4454SMAD5 levelsGCST904706780.68
4455VASP levelsGCST904710280.68
4456Goat cheese likingGCST900947730.68
4457Alanine transaminase (ALT, minimum, inv-norm transformed)GCST904751150.68
4458ENG/PEAR1 ratioGCST903146490.68
4459PPP1R12A/SPARC ratioGCST903157120.68
4460IDP dMRI ProbtrackX ICVF ifo rGCST900043880.67
4461KYNU/SCLY ratioGCST903152650.67
4462CKAP4 levelsGCST904687580.67
4463IDP dMRI ProbtrackX ISOVF slf rGCST900045470.67
4464Red cell distribution widthGCST900259880.67
4465DAPK2 levelsGCST902408770.67
4466THY1 levelsGCST904708610.67
4467ThalamNuclei lh volume MDlGCST900027240.67
4468FGD3 levelsGCST904692170.67
4469LBP levelsGCST904697430.67
4470IGFBP6 levelsGCST904695310.67
4471Valine levelsGCST901327520.67
4472CMC1 levelsGCST904687940.67
4473CD40LG/TRAF2 ratioGCST903138280.67
4474SPRY2 levelsGCST904707380.67
4475Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)FING000007550.67
4476CCL15/CCL23 ratioGCST903136810.67
4477Chronic hepatitis C infectionGCST900185850.67
4478Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005980.67
4479CDKN1A/PLA2G4A ratioGCST903139740.67
4480ADGRE5 levelsGCST904254840.67
4481HAVCR1 levelsGCST904694310.67
4482IL6ST/LEPR ratioGCST903151650.67
4483PRKG1 levelsGCST904703300.67
4484Diabetes type 2 with peripheral circulatory (PheCode 250.25)GCST904756780.67
4485MAPK13 levelsGCST902419490.66
4486aparc-a2009s rh area S-postcentralGCST900034370.66
4487SETMAR levelsGCST904706050.66
4488TXNRD1 levelsGCST904709940.66
4489Total Lipids in VLDLGCST905002340.66
4490Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009750.66
4491PPM1F levelsGCST904702970.66
4492Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256ECGA0002560.66
4493MAN1A2 levelsGCST904698430.66
4494STIP1/TMSB10 ratioGCST903158900.66
4495SEZ6L2 levelsGCST904706060.66
4496MELTF levelsGCST904698850.66
4497total creatine kinase (minimum, inv-norm transformed)GCST904764160.66
4498Omega-3 fatty acids to total fatty acids percentageGCST905020820.66
4499IDP dMRI ProbtrackX L2 str rGCST900042970.66
4500Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265ECGU0002650.66
4501GPLD1 levelsGCST900868900.66
4502AIF1 levelsGCST904682670.66
4503Maternal care for other conditions predominantly related to pregnancyFING000007910.66
4504Docosahexaenoic acid levelsGCST904972520.66
4505Hypertrophic scarFING000006420.66
4506Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010910.66
4507Polyunsaturated fatty acid levelsGCST904992710.66
4508Total concentration of lipoprotein particlesGCST905001030.66
4509DTI TBSS MO Middle cerebellar peduncleGCST903846200.66
4510NT5C3A/PRDX5 ratioGCST903155670.66
4511IDP dMRI TBSS FA Posterior thalamic radiation LGCST900039060.66
4512Later onset COPDFING000007140.66
4513CST6/GAL ratioGCST903143020.66
4514DTI TBSS MD Posterior corona radiata RGCST903845980.66
4515Excessive, frequent and irregular menstruationFING000005240.66
4516Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024110.66
4517Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T309ECGU0003090.66
4518Trihexosylcermide (d18:1/18:0) levelsGCST900247380.66
4519IDP T1 FAST ROIs L cerebellum VIIbGCST900025750.65
4520NAGPA levelsGCST904699960.65
4521Monounsaturated fatty acids to total fatty acids percentageGCST905023850.65
4522Triglycerides to Total Lipids in Medium VLDL percentageGCST904990730.65
4523DTI TBSS MD Superior fronto-occipital fasciculus RGCST903846140.65
4524Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T253ECGA0002530.65
4525Lysoalkylphosphatidylcholine (O-20:0) levelsGCST900254320.65
4526T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124)GCST903209430.65
4527DSG2 levelsGCST904237660.65
4528Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T328ECGA0003280.65
4529PLTP levelsGCST904702620.65
4530Facial pigmentation measurement (polar light)GCST900022840.65
4531N-palmitoyl-heptadecasphingosine (d17:1/16:0) levelsGCST902001150.65
4532FAM171B levelsGCST904691830.65
4533Cholesterol in IDLGCST904974950.65
4534INSR levelsGCST902415090.65
4535RECK levelsGCST904704450.65
4536CGREF1 levelsGCST904687350.65
4537AGR3 levelsGCST904682540.65
4538TARBP2/TDRKH ratioGCST903159020.65
4539Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T163ECGA0001630.65
4540CDC26 levelsGCST904686630.65
4541MNDA/NCF2 ratioGCST903154720.65
4542Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T267ECGU0002670.65
4543Artrosis, including avohilmoFING000001120.65
4544Caries in Clefts patientsFING000002560.65
4545ASAH1 levelsGCST904683730.65
4546T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903206840.65
4547BRAP levelsGCST904684640.65
4548Cryptic phenotype that captures alpha-1-antitrypsin deficiency severityGCST901018250.65
4549RBKS levelsGCST904704330.65
4550Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST902697210.65
4551TriglyceridesGCST0022160.65
4552Breathing problems responsible for leaving job | Employment historyUKBB000001120.65
4553Erectile dysfunction [ED] (PheCode 605)GCST904761610.65
4554Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T159ECGA0001590.65
4555MICB or MICA levelsGCST904699050.65
4556BACH1/NFATC1 ratioGCST903134440.65
4557SNAP23/TBL1X ratioGCST903158560.65
4558ISM1 levelsGCST904696300.65
4559Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494ECGA0004940.65
4560Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76ECGA0000760.65
4561DTI TBSS L3 Sagittal stratum LGCST903845550.65
4562Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188ECGU0001880.64
4563HSPA1A levelsGCST904694870.64
4564SH3BP1 levelsGCST904706190.64
4565REST UKBBICA NODEamps25 0016GCST903854990.64
4566SUSD2 levelsGCST904707870.64
4567EDAR levelsGCST904255560.64
4568ZBTB16 levelsGCST904710950.64
4569Seronegative rheumatoid arthritisFING000012960.64
4570IDP dMRI TBSS ICVF Posterior thalamic radiation LGCST900043560.64
4571PPP3R1 levelsGCST904703070.64
4572RTN4IP1 levelsGCST904705070.64
4573Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T194ECGA0001940.64
4574Sphingomyelin_38:1_[M+H]1+ levelsGCST900603060.64
4575CHRDL1 levelsGCST904687500.64
4576Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61ECGA0000610.64
4577GRPEL1 levelsGCST904694050.64
4578ALDH1A1 levelsGCST904682800.64
4579Biological Father: High blood pressureGCST904752430.64
4580Bone marrow fat fraction of thoracic vertebra 10GCST906523820.64
4581Ceramide (d16:1/22:0) levelsGCST900240260.64
4582aseg lh volume CerebralWhiteMatterGCST900026150.64
4583Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T292ECGA0002920.64
4584CWC15 levelsGCST904689200.64
4585aparc-Desikan rh volume supramarginalGCST900028310.64
4586Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T252ECGA0002520.64
4587SPINK2 levelsGCST904707220.64
4588Urine N-acetylglutamate levels in chronic kidney diseaseGCST902655690.64
4589TIMM10 levelsGCST904708670.64
4590Other disorders of eye and adnexaFING000010250.63
4591Eye problems/disorders - Glaucoma | EyesightUKBB000002310.63
4592Triglycerides to Total Lipids in Small LDL percentageGCST904997260.63
4593Cholesterol in medium HDL (UKB data field 23568)GCST902696650.63
4594Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025960.63
4595DTI TBSS MD Sagittal stratum RGCST903846020.63
4596Insomnia complaintsGCST0064870.63
4597Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T334ECGA0003340.63
4598Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T344ECGU0003440.63
4599ThalamNuclei lh volume L-SgGCST900027160.63
4600VEGFD levelsGCST904710370.63
4601HGF/MMP8 ratioGCST903150550.63
4602Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T262ECGU0002620.63
4603Cancer of liver and intrahepatic bile duct (PheCode 155)GCST904755680.63
4604FST levelsGCST900120800.63
4605LILRA2 levelsGCST904697710.63
4606Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006650.63
4607Sleep disorders | neurologicalUKBB000007760.63
4608Osteoarthritis; localized | musculoskeletalUKBB000005950.63
4609IDP dMRI TBSS ICVF Body of corpus callosumGCST900043300.63
4610Triacylglycerol_45:4_[M+NH4]1+ levelsGCST900603330.63
4611TRIM58 levelsGCST904709690.63
4612Concentration of large VLDL particlesGCST904982230.63
4613Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)GCST900426780.63
4614Triglycerides in medium VLDLGCST904990640.63
4615ADAM12 levelsGCST904682160.63
4616SNAP25 levelsGCST904706910.63
4617Leucine levels (UKB data field 23466)GCST902695630.63
4618SLA2 levelsGCST904706480.63
4619Milk type used - Full cream | DietUKBB000004680.63
4620CA1 levelsGCST904685100.63
4621Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T388ECGU0003880.63
4622Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney diseaseGCST902660450.63
4623Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T123ECGA0001230.63
4624FLT1/TFPI2 ratioGCST903148560.63
4625Benign neoplasm of colon | neoplasmsUKBB000000920.63
4626Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T351ECGU0003510.63
4627T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83)GCST903209020.63
4628ENTPD5 levelsGCST904691210.63
4629Cholesterol levels in very large VLDLGCST905005170.63
4630DARS1 levelsGCST904689470.62
4631Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T489ECGU0004890.62
4632LCN2/PRTN3 ratioGCST903153070.62
4633DBNL/PDGFB ratioGCST903144220.62
4634Cholesterol esters in very large HDLGCST905003540.62
4635Fractured bone site(s) - Wrist | Medical conditionsUKBB000002570.62
4636Triglycerides to total lipids ratio in large VLDLGCST900928790.62
4637Other disorders of circulatory system | circulatory systemUKBB000006070.62
4638ADAMTS16 levelsGCST904682240.62
4639potassium (minimum, inv-norm transformed)GCST904763100.62
4640Saturated fatty acids to total fatty acids percentageGCST905026840.62
4641Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122ECGU0001220.62
4642Human herpes virus 7 U14 antibody levelsGCST900069090.62
4643Illnesses of mother - Diabetes | Family historyUKBB000003470.62
4644TACC3 levelsGCST904707970.62
4645Linoleic acid levelsGCST905023110.62
4646Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T345ECGU0003450.62
4647aparc-Desikan rh thickness lateraloccipitalGCST900034890.62
4648Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73ECGA0000730.62
4649Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T254ECGA0002540.62
4650RNF5 levelsGCST904704880.62
4651Omega-3 fatty acid levelsGCST905024360.62
4652FAM3C/NECTIN2 ratioGCST903147810.62
4653Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T146ECGA0001460.62
4654IDP dMRI TBSS FA Middle cerebellar peduncleGCST900038770.62
4655Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T234ECGU0002340.62
4656NTRK3 levelsGCST904700980.62
4657Left-hemisphere visual network to thalamus white-matter structural connectivityGCST903026620.62
4658Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465ECGU0004650.62
4659Other and unspecified anaemiasFING000009250.62
4660GRSF1 levelsGCST904694070.62
4661Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201ECGA0002010.62
4662GDI2 levelsGCST900880040.62
4663Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025700.62
4664Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006950.62
4665Phospholipids to total lipids ratio in very large VLDLGCST900930250.62
4666Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T300ECGA0003000.62
4667Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189ECGU0001890.62
4668Free cholesterol in very large HDLGCST905003800.61
4669aparc-DKTatlas rh thickness pericalcarineGCST900035900.61
4670T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26)GCST903205890.61
4671aparc-a2009s rh area G-oc-temp-lat-fusiforGCST900033910.61
4672Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levelsGCST903180130.61
4673Triglycerides in large LDLGCST904980760.61
4674MCAM/NCAM1 ratioGCST903154080.61
4675CD40/TIMP3 ratioGCST903138290.61
4676Omega-6 fatty acids to total fatty acids percentageGCST905021290.61
4677IDP dMRI TBSS MD Posterior limb of internal capsule RGCST900040450.61
4678Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T241ECGA0002410.61
4679Free Cholesterol to Total Lipids in Very Large HDL percentageGCST905003980.61
4680IDP dMRI TBSS L2 Uncinate fasciculus RGCST900041670.61
4681Linoleic acid to total fatty acids percentageGCST905023370.61
4682Primary gonarthrosis, bilateralFING000012130.61
4683Triglycerides in medium LDLGCST904988640.61
4684Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477ECGU0004770.61
4685ACAN levelsGCST904681960.61
4686Duodenal ulcerFING000004810.61
4687ACYP2 levelsGCST902401870.61
4688aparc-a2009s lh area S-centralGCST900033410.61
4689CHRDL2 levelsGCST904687510.61
4690Radial peak diastolic strain rateGCST900190140.61
4691FOXO3/SH2B3 ratioGCST903148810.61
4692Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T347ECGU0003470.61
4693Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499ECGU0004990.61
4694aparc-Desikan rh area supramarginalGCST900031370.61
4695Concentration of medium HDL particles (UKB data field 23565)GCST902696620.61
4696X-24947 levelsGCST902006510.61
4697Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82ECGA0000820.61
4698ENG/TNFSF10 ratioGCST903146510.61
4699Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145ECGA0001450.61
4700Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T148ECGU0001480.61
4701Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T251ECGA0002510.61
4702GSTA1 levelsGCST904694110.61
4703Left ventricular end diastolic massGCST902681230.61
4704L3HYPDH levelsGCST904697240.61
4705Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T339ECGA0003390.60
4706Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T67ECGA0000670.60
4707Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T260ECGA0002600.60
4708Smoking status - Current | SmokingUKBB000007790.60
4709wg rh intensity-contrast superiorparietalGCST900038550.60
4710IGSF3 levelsGCST904695390.60
4711KLK6/MOG ratioGCST903152550.60
4712ALCAM levelsGCST904682790.60
4713S100A12 levelsGCST904705130.60
4714EFEMP1/IL18BP ratioGCST903145960.60
4715TBCC levelsGCST904708140.60
4716IDP T1 FAST ROIs R cerebellum IXGCST900025860.60
4717Chronic heart failureGCST900185860.60
4718CD55/CHI3L1 ratioGCST903138450.60
4719CELA3A/CPA1 ratioGCST903140090.60
4720ZFYVE19 levelsGCST904710980.60
4721Septal defectsFING000012930.60
4722Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T264ECGU0002640.60
4723Multi-trait sex scoreGCST902701160.60
4724SNCG levelsGCST904706950.60
4725Volume of right cortical nucleusGCST904749190.60
4726Cholesteryl Esters in Small VLDLGCST904997860.60
4727Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T99ECGU0000990.60
4728Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T103ECGA0001030.60
4729SKAP2 levelsGCST904706460.60
4730FLT4 levelsGCST904692520.60
4731Sleep disorders | Episodic and paroxysmal disordersUKBB000007750.59
4732HARS1 levelsGCST904694300.59
4733Other heart diseasesFING000010570.59
4734TNFAIP8L2 levelsGCST904708970.59
4735Total triglycerides levelsGCST905001260.59
4736Cancer of bladder (PheCode 189.2)GCST904755980.59
4737SDCCAG8 levelsGCST904705600.59
4738Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T249ECGA0002490.59
4739Gastric ulcerGCST900186310.59
4740STIP1 levelsGCST904707640.59
4741Total Lipids in VLDLGCST905002360.59
4742IDP dMRI TBSS ISOVF Corticospinal tract RGCST900044830.59
4743CD99L2/CPM ratioGCST903139250.59
4744DTI TBSS L2 Superior longitudinal fasciculus LGCST903845170.59
4745IDP dMRI TBSS ICVF Uncinate fasciculus RGCST900043710.59
4746Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248ECGU0002480.59
4747HSPG2/PTGDS ratioGCST903150920.59
4748HEXIM1/IKBKG ratioGCST903150450.59
4749Treatment/medication code - quinine | MedicationsUKBB000008550.59
4750IDP dMRI ProbtrackX MD str rGCST900042430.59
4751Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005650.59
4752IDP T1 FAST ROIs L cerebellum VGCST900025640.59
4753Docosahexaenoic acid levelsGCST905022580.59
4754APEX1 levelsGCST904683290.59
4755Right-hemisphere salience/ventral attention network to putamen white-matter structural connectivityGCST903028190.59
4756AGRP levelsGCST900120630.59
4757PLAU levelsGCST904702520.59
4758VEGFC levelsGCST904710360.59
4759CD302 levelsGCST904686240.59
4760IritisGCST900186510.59
4761Free cholesterol in very large VLDLGCST905005750.59
4762Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900241950.59
4763RRM2 levelsGCST904705010.59
4764TNFSF13 levelsGCST904709210.58
4765Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T250ECGA0002500.58
4766Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021550.58
4767Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116ECGU0001160.58
4768HTRA2/SNAP29 ratioGCST903150980.58
4769CD69/SNAP29 ratioGCST903138870.58
4770Wears glasses or contact lenses (UKB data field 2207)GCST900428750.58
4771CCL17 levelsGCST904685690.58
4772FKBP7 levelsGCST904692450.58
4773Phospholipids to total lipids ratio in very small VLDLGCST900930370.58
4774ICD10 O14: Pre-eclampsiaGCST904542330.58
4775SEPHS1 levelsGCST902427400.58
4776BA-exvivo rh volume BA4aGCST900028530.58
4777IDP dMRI TBSS FA External capsule RGCST900039090.58
4778Wears glasses or contact lenses | EyesightUKBB000009070.58
4779Seborrheic keratosis (PheCode 702.2)GCST904762060.58
4780Other circulatory problemGCST904752170.58
4781AMBP/ASGR1 ratioGCST903132510.58
4782NRP2 levelsGCST904700860.58
4783Total lipids in medium VLDLGCST904989940.58
4784Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383ECGA0003830.58
4785LBR/MAD1L1 ratioGCST903152950.58
4786Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T91ECGA0000910.58
4787T1 FreeSurfer aseg Left-PutamenGCST903841450.58
4788Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)FING000008660.58
4789JAM2/THBD ratioGCST903152390.58
4790PLA2G15/SMPDL3A ratioGCST903156630.58
4791Lung volumeGCST900166680.58
4792LRRC37A2 levelsGCST904698020.58
4793Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992870.58
4794Phospholipid levels in very large HDLGCST900930120.58
4795PENK levelsGCST904702080.58
4796IDP T1 FAST ROIs L cerebellum crus IIGCST900025720.58
4797Diacylglycerol_32:2_[M+H-H2O]1+ levelsGCST900601680.58
4798Brain glioblastoma, excluding all cancers (controls excluding all cancers)FING000002250.58
4799Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472ECGU0004720.57
4800Triglycerides to Total Lipids in Large HDL percentageGCST904979060.57
4801Rheumatoid arthritis (PheCode 714.1)GCST904762300.57
4802MCFD2/VSIR ratioGCST903154110.57
4803Guanidinoacetate levelsGCST902003840.57
4804DSCAM levelsGCST904690410.57
4805VSIG4 levelsGCST904710520.57
4806B4GAT1 levelsGCST904684130.57
4807BECN1 levelsGCST904684380.57
4808CLEC1B/ITGB5 ratioGCST903140940.57
4809Cholesteryl Esters in Medium HDLGCST904985320.57
4810Tea with sugar likingGCST900948570.57
4811Mackerel likingGCST900947960.57
4812T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST903206850.57
4813Cholesterol_[M+H-H2O]1+ levelsGCST900601330.57
4814MEPE levelsGCST904698890.57
4815AGRP/NPY ratioGCST903132030.57
4816Other diseases of blood and blood-forming organs, wideFING000009990.57
4817Recent trouble relaxing | AnxietyUKBB000007450.57
4818Phenylalanine levelsGCST904992280.57
4819PLAUR/PRSS8 ratioGCST903156750.57
4820C1QTNF1/COL18A1 ratioGCST903135510.57
4821CCL17/CD69 ratioGCST903136840.57
4822DTI TBSS L2 Splenium of corpus callosumGCST903844800.57
4823CYB5R2 levelsGCST904689370.57
4824ARHGAP1/SPARC ratioGCST903133440.57
4825rfMRI connectivity (ICA100 edge 1066)GCST900059190.57
4826Irritable moodGCST0069410.57
4827aseg lh number HolesBeforeFixingGCST900026300.57
4828SERPINF2 levelsGCST904705990.57
4829IDP dMRI TBSS MD Genu of corpus callosumGCST900040290.57
4830F3/GFRA1 ratioGCST903147410.57
4831DTI autoptx L3 slf r tractGCST903852150.57
4832IDP T1 FAST ROIs L cerebellum XGCST900025870.57
4833ADD1 levelsGCST904682330.57
4834Other contact dermatitisFING000009900.56
4835Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T341ECGU0003410.56
4836Cholesteryl Esters in Large HDLGCST904977510.56
4837Treatment/medication code - seretide 50 evohaler | MedicationsUKBB000008580.56
4838Interpolated Year when operation took place | OperationsUKBB000003720.56
4839High density lipoprotein cholesterol levelsGCST902396510.56
4840Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levelsGCST900603750.56
4841T1 FreeSurfer a2009s lh S postcentral volumeGCST903848820.56
4842Omega-6 fatty acids to total fatty acids percentageGCST905021210.56
4843Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T144ECGA0001440.56
4844aseg lh volume choroid-plexusGCST900026290.56
4845Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591)GCST902696880.56
4846Disorders of sclera, cornea, iris and ciliary bodyFING000004580.56
4847IDP dMRI TBSS FA Superior fronto-occipital fasciculus RGCST900039190.56
4848Migraine without auraFING000008210.56
4849Spread type: Any oil based spread vs never use spread (UKB data field 1428)GCST901329490.56
4850BPIFB1 levelsGCST904684620.56
4851Monounsaturated fatty acid levelsGCST904990900.56
4852NID1 levelsGCST904700470.56
4853MAP3K5 levelsGCST904698540.56
4854Volume of right anterior amygdaloid areaGCST904750000.56
4855Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T291ECGA0002910.56
4856Triglyceride levelsGCST902396630.56
4857Cancer within the respiratory system (PheCode 165)GCST904755710.56
4858Sphingomyelin_34:1_[M+H]1+ levelsGCST900602390.56
4859BACH1/DIABLO ratioGCST903134370.56
4860ALPP/MSLN ratioGCST903132500.56
4861ATP5IF1/METAP1D ratioGCST903133910.56
4862Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T158ECGA0001580.56
4863PLIN3/VSIR ratioGCST903156790.56
4864Sequelae of cerebrovascular diseaseFING000012940.56
4865Vegetable intake (standard GWA)GCST902673060.56
4866CSF1 levelsGCST904688810.56
4867Urine methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655090.56
4868Neutrophil countGCST900259770.56
4869FGR/LBR ratioGCST903148140.56
4870LGALS3 levelsGCST900120090.56
4871KRT5 levelsGCST904697180.55
4872CDH17 levelsGCST904686690.55
4873PON2 levelsGCST904702860.55
4874Monounsaturated fatty acids to total fatty acids percentageGCST905020490.55
4875ICD10 N97.0: Female infertility associated with anovulationGCST904542230.55
4876Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259ECGA0002590.55
4877Phosphatidylcholine (34:5) levelsGCST900242860.55
4878Reaction timeGCST0034990.55
4879Cholesteryl esters in very large VLDLGCST905005560.55
4880CAG-177 sp003538135 abundance in stoolGCST900322600.55
4881Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T350ECGU0003500.55
4882Trunk fat mass | Impedance measuresUKBB000008630.55
4883AXIN1 levelsGCST904684050.55
4884CCL17/CCL22 ratioGCST903136820.55
4885NUCB2/TXNDC5 ratioGCST903155780.55
4886IL1R1 levelsGCST904255630.55
4887Recent feelings of foreboding | AnxietyUKBB000007380.55
4888Phospholipids in medium HDLGCST904986350.55
4889Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T265ECGA0002650.55
4890Left molecular layer hippocampal volume (body)GCST902679530.55
4891Free cholesterol in medium VLDLGCST904989600.55
4892Triglycerides to Total Lipids in Small VLDL percentageGCST904999220.55
4893Cough on most days | Medical informationUKBB000001530.55
4894Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109ECGU0001090.55
4895Cholesterol in Large HDLGCST904977090.55
4896IGF1R levelsGCST904695240.55
4897FKBP1B/PRDX5 ratioGCST903148330.55
4898CX3CL1/DSG2 ratioGCST903143230.55
4899XG levelsGCST904710820.55
4900Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST900930420.55
4901Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T307ECGU0003070.55
4902DTI TBSS L2 Sagittal stratum LGCST903845070.55
4903CXCL11/VTA1 ratioGCST903143370.55
4904CataractsGCST904753820.55
4905Phospholipid levels in chylomicrons and extremely large VLDLGCST905010310.54
4906Peptic ulcer diseaseGCST902709260.54
4907DTI TBSS L2 External capsule LGCST903845090.54
4908Total lipids in small VLDLGCST904998490.54
4909Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T299ECGA0002990.54
4910Lung cancer in never smokersGCST902774340.54
4911Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T216ECGU0002160.54
4912CLEC1B/LGALS8 ratioGCST903140960.54
4913HNMT levelsGCST904694680.54
4914High myopiaGCST0099620.54
4915Cholesterol levels in chylomicrons and extremely large VLDLGCST900930400.54
4916Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T203ECGU0002030.54
4917COMP/ICAM1 ratioGCST903141890.54
4918TGFB1 levelsGCST904708430.54
4919MSRA levelsGCST904699510.54
4920Allergic rhinitisFING000000710.54
4921IGSF8 levelsGCST904695400.54
4922AHCY levelsGCST904682590.54
4923Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T161ECGA0001610.54
4924Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T441ECGA0004410.54
4925mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754440.54
4926Free cholesterol in medium LDLGCST904987670.54
4927AXIN1/DOK2 ratioGCST903134060.54
4928CDH5/PEAR1 ratioGCST903139590.54
4929TIMP3/ZBTB16 ratioGCST903159210.54
4930Wet age-related macular degenerationFING000014480.54
4931Lipoma of skin and subcutaneous tissue (PheCode 214.1)GCST904756190.54
4932Cholesteryl Esters in Small LDLGCST904995780.54
4933Deoxycholic acid glucuronide metabolite levelGCST906162290.54
4934Degree of unsaturationGCST905022300.54
4935Pizza likingGCST900948100.54
4936Cholesterol to total lipids ratio in small LDLGCST900929570.54
4937VTA1 levelsGCST904710580.54
4938aparc-a2009s lh volume S-circular-insula-supGCST900029730.54
4939triglyceride (minimum, inv-norm transformed)GCST904764370.54
4940Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T495ECGU0004950.54
4941BANK1 levelsGCST904684210.54
4942aparc-a2009s lh area S-orbital-med-olfactGCST900033590.53
4943Turnip likingGCST900948610.53
4944Diseases of esophagus | digestiveUKBB000001840.53
4945Cholesteryl Esters in IDLGCST904975230.53
4946Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T322ECGA0003220.53
4947IRAK1/NFATC1 ratioGCST903151940.53
4948SERPINA12 levelsGCST904705810.53
4949Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478ECGU0004780.53
4950Beta-hydroxyisovaleroylcarnitine levelsGCST901998020.53
4951ADGRE5/ITGB2 ratioGCST903131800.53
4952Maximum workload during fitness test | ECG during exerciseUKBB000004320.53
4953MPHOSPH8 levelsGCST904699340.53
4954Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380ECGA0003800.53
4955Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T263ECGU0002630.53
4956PDLIM7/TBC1D23 ratioGCST903156400.53
4957Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T329ECGA0003290.53
4958MDK levelsGCST904698770.53
4959Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)?GCST904752100.53
4960Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T129ECGA0001290.53
4961Phospholipids to total lipids in small HDL percentage (UKB data field 23644)GCST902697410.53
4962CoxarthrosisFING000003620.53
4963Phosphatidylcholine (40:8) levelsGCST900242990.53
4964FSTL3 levelsGCST904257650.53
4965Physical activity (Relative amplitude)GCST900614320.53
4966PDCD6 levelsGCST904701830.53
4967Operation code - hip replacement/revision | OperationsUKBB000005580.53
4968ITGB1/VASN ratioGCST903152320.53
4969Other venous embolism and thrombosis (PheCode 452)GCST904760070.53
4970IMPA1/TBCC ratioGCST903151750.53
4971NCAN levelsGCST904700050.53
4972SMOC2 levelsGCST900600590.52
4973aparc-a2009s rh thickness G-temporal-middleGCST900037140.52
4974STX16 levelsGCST904707690.52
4975HippSubfield rh volume subiculum-headGCST900026930.52
4976Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474ECGU0004740.52
4977OGN levelsGCST904701190.52
4978ITGB1BP2 levelsGCST900120580.52
4979ABHD14B/SPARC ratioGCST903131460.52
4980OSMR levelsGCST904701320.52
4981Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588)GCST902696850.52
4982Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208ECGA0002080.52
4983RASSF2 levelsGCST904704310.52
4984ATRN levelsGCST904684000.52
4985IL12A_IL12B/LAG3 ratioGCST903151470.52
4986IDP T1 FAST ROIs R lingual gyrusGCST900025220.52
4987Depression | Mental distressUKBB000001650.52
4988CRTAM/FCRL6 ratioGCST903142740.52
4989F13B levelsGCST904691670.52
4990FAM171B levelsGCST900903390.52
4991CLEC1B/DAB2 ratioGCST903140860.52
4992Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434ECGU0004340.52
4993Monounsaturated fatty acids to total fatty acids percentageGCST904991090.52
4994Saturated fatty acids levelsGCST905021940.52
4995Triglycerides in IDLGCST904976710.52
4996Triglycerides to total lipids in small HDL percentage (UKB data field 23648)GCST902697450.52
4997Omega-3 fatty acid levelsGCST905020620.52
4998CD40LG/MPIG6B ratioGCST903138250.52
4999IDP T1 FAST ROIs R ventral striatumGCST900025600.52
5000N-acetylphenylalanine levelsGCST902006770.52